Company news
OraSure Technologies, Inc. news in 2020
OraSure Technologies, Inc.'s news releases, calls and decks from 2020, newest first.
OraSure’s OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test
December 22, 2020
OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 Antibody Test
December 20, 2020
OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments
November 3, 2020
OraSure’s DNA Genotek Subsidiary Receives FDA Emergency Use Authorization for its ORAcollect®·RNA Saliva Collection Device for SARS CoV-2
November 2, 2020
OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5: 00 p.m. ET
October 20, 2020
OraSure’s OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2
October 18, 2020
OraSure Technologies, Inc. Announces 2020 Second Quarter Financial Results and Update on COVID-19 Testing Programs
August 4, 2020
OraSure’s OMNIgene®·ORAL Device Included in EUA Granted to Clinical Reference Laboratory for Self-Collected SARS-CoV-2 Saliva Test
July 30, 2020
OraSure Technologies to Hold Second Quarter 2020 Earnings Conference Call on August 5th, 2020
July 21, 2020
OraSure Technologies Receives BARDA Funding for Coronavirus Antibody ELISA Using Oral Fluid Samples
June 9, 2020
OraSure’s Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test
June 7, 2020
OraSure Technologies, Inc. Announces Exercise of Option to Purchase Additional Shares of Common Stock
June 2, 2020
OraSure Technologies, Inc. Prices Underwritten Offering of Common Stock
June 1, 2020
OraSure Technologies, Inc. Announces Proposed Public Offering of Common Stock
May 31, 2020
OraSure Technologies, Inc. Announces Purchase of UrSure, Inc.
May 28, 2020
OraSure Technologies Appoints Lelio Marmora to Board of Directors
May 28, 2020
OraSure’s OMNIgene®·ORAL Kit Included in EUA Granted to P23 Labs for At-Home Collection of Saliva Samples for SARS-CoV-2 Test
May 21, 2020
OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 19, 2020
May 13, 2020
OraSure Technologies, Inc. Consolidates Microbiome Services Subsidiaries
May 11, 2020
OraSure Announces 2020 First Quarter Financial Results and Provides COVID-19 Update
May 5, 2020
OraSure Technologies Appoints Lisa Nibauer as Infectious Disease Business Unit Lead
May 4, 2020
OraSure Technologies Appoints David J. Shulkin, M.D. to Board of Directors
April 7, 2020
OraSure Technologies Receives BARDA Contract for Rapid Oral Fluid Pan-SARS-Coronavirus In-home Self-test
April 5, 2020
OraSure Announces 2019 Full Year and Fourth Quarter Financial Results
February 18, 2020
Decks in 2020
- Investor Presentation (December 2020)
Investor deck · 23 slides · Dec 21, 2020
- Investor Presentation (November 2020)
Investor deck · 23 slides · Nov 5, 2020
- Investor Presentation (September 2020)
Investor deck · 23 slides · Sep 1, 2020
- Corporate Update (August 2020)
Corporate update · 6 slides · Aug 25, 2020
- Fact Sheet (August 2020)
Fact sheet · 2 slides · August 2020